Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

in vitro gene mutation study in bacteria
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: According to the OECD Guideline and GLP

Data source

Referenceopen allclose all

Reference Type:
study report
Report date:
Reference Type:
other: abstract

Materials and methods

Test guidelineopen allclose all
according to guideline
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
according to guideline
other: EEC Directive 92/69, L 383 A, Annexe V, B 14
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Details on test material:
Ro 1525 corresponds to Colipa A 155
Ro 1525
SAT 9803 75
Batch-No.: Ro-Rn 6567-083


Target gene:
TA1537: his C 3076; da-; uvrB- frame shift mutations
TA 98: his D 3052; rfa-; uvrB-;R-factor frame shift mutations
TA1535: his G 46; rfa-; uvrB- base-pair substitutions
TA 100: his G 46; rfa-; uvrB;R-factor base-pair substitutions
TA 102: his G 428; rfa'; uvrB';R-factor base-pair substitutions
Species / strain
Species / strain / cell type:
other: Salmonella typhimurium strain: TA 98, TA 100, TA 102, TA 1535, TA 1537
Metabolic activation:
with and without
Metabolic activation system:
Phenobarbitallß-Naphthoflavone induced rat liver S9 is used as the metabolic activation system. The S9 is prepared from 8 - 12 weeks old male Wistar Hanlbm rats.
Test concentrations with justification for top dose:
33, 100, 333, 1000, 2500 and 5000 ug/plate
Vehicle / solvent:
deionised water
Untreated negative controls:
Negative solvent / vehicle controls:
True negative controls:
Positive controls:
Positive control substance:
other: Without metabolic activation: sodium azide (TA1535, TA 100), 4-nitro-o-phenylene-diamine (TA 1537, TA 98), methyl methane sulfonate (TA 102). With metabolic activation: 2-aminoanthracene (all strain)
Details on test system and experimental conditions:
The histidine dependent strains are derived fiom S. typhimurium strain LT2 through a
mutation in the histidine locus. Additionally due to the "deep rough" (rfa-minus) mutation
they possess a faulty lipopolysaccharide envelope which enables substances to penetrate the
cell wall more easily. A hrther mutation causes an inactivation of the excision repair
system. The latter alteration includes mutational processes in the nitrate reductase and biotin
genes produced in a UV-sensitive area of the gene named "uvrB-minus". In the strains TA
98 and TA 100 and TA 102 the R-factor plasmid pKM 10 1 carries the ampicillin resistance
marker. The strain TA 102 does not contain the uvrB--mutation and is excision repair
proficient. Additionally, TA 102 contains the multicopy plasmid pAQ 1 carrying the hisG428
mutation (ochre mutation in the hisG gene ) and a tetracycline resistance gene.
Evaluation criteria:
Regular checking of the properties of the strains regarding the membrane permeability,
ampicillin- and tetracycline-resistance as well as spontaneous mutation rates is performed in
the laboratory of RCC Cytotest Ce11 Research according to Ames et al. (1). In this way it
was ensured that the experimental conditions set down by Arnes were fulfilled.

Results and discussion

Test results
Species / strain:
other: TA 98, TA 100, TA 102, TA 1535, TA 1537
Metabolic activation:
with and without
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
Untreated negative controls validity:
Positive controls validity:
Remarks on result:
other: other: Salmonella typhimurium
Migrated from field 'Test system'.

Applicant's summary and conclusion

Interpretation of results (migrated information):

In conclusion, it can be stated that during the described mutagenicity test and under the
experimental conditions reported, the test article did not induce gene mutations by base pair
changes or fiamechifis in the genome of the strains used.
with S9 mix
without S9 mix
1000 - 5000
Therefore, Ro 1525 is considered to be non-mutagenic in this Salmonella typhimurium
reverse mutation assay.
Executive summary:

This study was performed to investigate the potential of Ro 1525 to induce gene mutations

according to the plate incorporation test (experiment I) and the pre-incubation test

(experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98,

TA 100. and TA 102.

The assay was performed in two independent experiments both with and without h e r

microsomal activation. Each concentration, including the controls, was tested in triplicate.

The test article was tested at the following concentrations:

33; 100; 333; 1000; 2500; and 5000 pg/plate

The background growth was reduced at concentrations as low as 333 pglplate in the first

and at 100 pg/plate and above in the second experiment without metabolic activation.

No substantial increase in revertant colony numbers of any of the five tester strains was

observed following treatment with Ro 1525 at any dose level, neither in the presence nor

absence of metabolic activation (S9 mix). There was also no tendency of higher mutation

rates with increasing concentrations in the range below the generally acknowledged border

of biological relevance.

Appropriate reference mutagens were used as positive controls and showed a distinct increase

of induced revertant colonies.